Ranjeev Krishana
Director/Board Member at BEIGENE, LTD.
Net worth: - $ as of 2024-03-30
Profile
Ranjeev Krishana is an Independent Non-Executive Director at BeiGene Ltd.
and a Director at Sironax Ltd.
He previously worked as a Director at Pfizer Inc. from 2004-2007 and as a Senior Regional Director from 2008-2011.
He was also the Head of International Investments at Baker Bros.
Advisors LP.
Prior to that, he worked as a Consultant at Andersen Consulting (Minnesota) from 1995-1997 and as a Manager at Accenture LLC from 1995-2001.
Krishana received his undergraduate degree from Brown University in 1995 and his graduate degree from Harvard University in 2001.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
BEIGENE LTD
-.--% | 2023-06-14 | 0 ( -.--% ) | - $ | 2024-03-30 |
Ranjeev Krishana active positions
| Companies | Position | Start |
|---|---|---|
| BEIGENE, LTD. | Director/Board Member | 2014-09-30 |
Sironax Ltd.
 Sironax Ltd. Pharmaceuticals: MajorHealth Technology Sironax Ltd. is a clinical-stage biotechnology company located in Beijing, China. The Chinese company is dedicated to discovering and developing novel treatments for patients with age-related degenerative diseases. Sironax has built a diverse pipeline of multiple programs, focusing on key mechanisms underlying age-related degenerative diseases including regulated cell death, neuroprotective pathways, and neuroinflammation. Currently, Sironax is conducting early clinical studies with sir0365 and sir2446, in addition to ongoing preclinical research. | Director/Board Member | - |
Former positions of Ranjeev Krishana
| Companies | Position | End |
|---|---|---|
| PFIZER, INC. | Corporate Officer/Principal | 2011-03-31 |
| PFIZER, INC. | Corporate Officer/Principal | 2006-12-31 |
Accenture LLC
 Accenture LLC Miscellaneous Commercial ServicesCommercial Services Accenture LLC operates as a global management consulting, technology services and outsourcing company. The company is headquartered in Reston, VA. | Corporate Officer/Principal | 2000-12-31 |
| Andersen Consulting (Minnesota) | Corporate Officer/Principal | 1996-12-31 |
Baker Bros. Advisors LP
 Baker Bros. Advisors LP Investment ManagersFinance Baker Bros. Advisors LP (BBA) is an independent, SEC-registered investment advisor and hedge fund manager headquartered in New York City. The firm was founded by Julian Baker and Felix Baker in 2000 and do-business-as Baker Brothers Investments. BBA serves as a discretionary investment advisor to pooled investment vehicles operating as private investment funds and to a managed account. | Portfolio Manager-Equities | - |
Training of Ranjeev Krishana
| Brown University | Undergraduate Degree |
| Harvard University | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| PFIZER, INC. | Health Technology |
| BEIGENE, LTD. | Health Technology |
| Private companies | 4 |
|---|---|
Baker Bros. Advisors LP
Baker Bros. Advisors LP Investment ManagersFinance Baker Bros. Advisors LP (BBA) is an independent, SEC-registered investment advisor and hedge fund manager headquartered in New York City. The firm was founded by Julian Baker and Felix Baker in 2000 and do-business-as Baker Brothers Investments. BBA serves as a discretionary investment advisor to pooled investment vehicles operating as private investment funds and to a managed account. | Finance |
| Andersen Consulting (Minnesota) | |
Accenture LLC
Accenture LLC Miscellaneous Commercial ServicesCommercial Services Accenture LLC operates as a global management consulting, technology services and outsourcing company. The company is headquartered in Reston, VA. | Commercial Services |
Sironax Ltd.
Sironax Ltd. Pharmaceuticals: MajorHealth Technology Sironax Ltd. is a clinical-stage biotechnology company located in Beijing, China. The Chinese company is dedicated to discovering and developing novel treatments for patients with age-related degenerative diseases. Sironax has built a diverse pipeline of multiple programs, focusing on key mechanisms underlying age-related degenerative diseases including regulated cell death, neuroprotective pathways, and neuroinflammation. Currently, Sironax is conducting early clinical studies with sir0365 and sir2446, in addition to ongoing preclinical research. | Health Technology |
- Stock Market
- Insiders
- Ranjeev Krishana
